ORLADEYO (BEROTRALSTAT BUSINESS)

HQ - North Carolina

Summary

ORLADEYO (berotralstat) is a medication manufactured by BioCryst Pharmaceuticals for the prophylactic treatment of hereditary angioedema (HAE).

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 192 M

Avg. Deal Size£ 192 M

Market Context